Markham, Ontario, August 14, 2018 – PRESS RELEASE – The Flowr Group (Okanagan) Inc., a cultivator of cannabis in Canada, has announced that it... IGC to Enter California Market With Hyalolex

Markham, Ontario, August 14, 2018 – PRESS RELEASE – The Flowr Group (Okanagan) Inc., a cultivator of cannabis in Canada, has announced that it has received its sales license from Health Canada. The license enables Flowr to sell to the Canadian medical and adult-use recreational markets.

Flowr will begin selling to the medical market in the coming weeks and the recreational market when it opens in October. Flowr recently was selected by the British Columbia Liquor Distribution Branch to supply cannabis to province-owned dispensaries and the company is in discussions with other provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company has agreements in place with several major medical cannabis distributors as well.

Flowr’s premium cannabis will offer consumers and patients one of the highest quality sensory experiences available in the Canadian market. The company’s Kelowna, BC cultivation facilities meet pharmaceutical quality production standards which, along with exacting protocols designed by the Flowr team, enable the company to grow cannabis that exceeds Health Canada’s stringent quality standards without using taste-diminishing and smell-altering irradiation. Without the proper experience and protocols, most producers have to use irradiation to kill yeast, mold and bacteria on their flower to meet quality standards. The presence of these pathogens and use of irradiation both negatively affect the pleasurable scents and flavors of cannabis while introducing or enhancing negative scents and flavors.

“We’re pleased to have successfully completed the rigorous Health Canada sales licensing process and are excited to begin offering consumers and patients the high quality experience that Flowr cannabis provides,” said Steve Klein, Flowr’s co-founder, chairman and chief strategist. “This is another important step forward for Flowr in our journey to becoming the leading supplier of premium, non-irradiated cannabis to the Canadian medical and recreational markets.”

Initially, Flowr will offer two brands:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process-–from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )